Heerim Architects & Planners Co. Ltd (037440)
KOSDAQ · Korea · prices in KRW · close of 19 Oct 2026
Key indicators
| Last close | KRW 3,960.00 |
|---|---|
| 52-week range | 3,095.00 – 7,460.00 |
| Return, 1 month / 3 months | −4.8% / +7.6% |
| Return, 1 year / 3 years | −5.3% / −52.2% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 69.1% |
| Worst drawdown (1 year) | -55.3% |
| Average daily value traded | 2,280.55M KRW |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Heerim Architects and Planners is a South Korean architecture and engineering firm based in Seoul. It provides architectural planning, design and construction supervision services for clients in the public and private sectors. Its work covers a range of building types, including offices, residential developments, hospitals, cultural facilities and sports venues, both in Korea and in overseas markets. The company works with developers, government bodies and institutions that commission building projects.
Heerim Architects & Planners Co. Ltd trades under the code 037440 on the KOSDAQ in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Heerim Architects & Planners Co. Ltd (037440) trades on the KOSDAQ in Korea. It last closed at KRW 3,960.00 on 19 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 656 of 1,830 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 5.3% and over the last three months it rose 7.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 56 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -12.4% | ||
| From 52-week high | -46.9% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.6% | ||
| 6-month return | -36.2% | ||
| 12-month return, skipping the last month | -0.6% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 69.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -55.3% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 2,280.55M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.2% |
|---|---|
| 1 month | −4.8% |
| 3 months | +7.6% |
| 6 months | −36.2% |
| 1 year | −5.3% |
| 3 years | −52.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 4,122.50 / 4,519.96 |
|---|---|
| Golden / death cross (60 days) | Death, 55 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 186.85 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Dec 2025 | KRW 100.0000 |
| 27 Dec 2024 | KRW 150.0000 |
| 27 Dec 2023 | KRW 150.0000 |
| 28 Dec 2022 | KRW 150.0000 |
| 29 Dec 2021 | KRW 150.0000 |
| 29 Dec 2020 | KRW 150.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.